dr. A.W.J.M. (Andor) Glaudemans

Nuclear Medicine Physician


Research interests

The main research line is “Imaging I3”: Infection, Inflammation, and (tumor)Immunology


  • Musculoskeletal: peripheral osteomyelitis, device-related infections such as prosthetic joint infections, diabetic foot infection, fracture-related infections

  • Cardiovascular: endocarditis, device-related infections such as vascular graft infections, intravascular prosthetic material infections

  • Sepsis/bloodstream infections: bacteremia, specific bacterial infections

  • Fungal infections

  • Infections in children



  • Amyloidosis

  • Sarcoidosis

  • Tuberculosis, HIV/AIDS

  • Atherosclerosis and vasculitis

  • Rejection and PTLD after organ transplantation

  • Inflammatory diseases in children

  • Sports injuries



  • Imaging autoimmune reaction/checkpoints in tumors

  • Imaging of lymphocytes

  • Imaging of macrophages


Societal impact:

  • Development of diagnostic and therapeutic flowcharts in infectious and inflammatory diseases

  • Publication of several Dutch (NFU, NVNG) and European (EANM) guidelines/recommendations

  • Development and implementation of new specific tracers in infectious and inflammatory diseases (IL-2, PD1/PDL1, sorbitol, labelled antibiotics, labelled antifungal drugs)

  • Improvement of existing techniques for infection imaging (new protocols for white blood cell scintigraphy and FDG-PET)

  • Role of nuclear medicine in therapy evaluation of infectious and inflammatory diseases and during/after immunotherapy


Besides this Imaging I3 research line, I also perform some research in the field of oncology (this is also the main differential diagnosis with infectious diseases in PET):

  • Imaging of hormonal receptors (FES-PET, FDHT-PET)

  • Imaging of brain tumors

  • Imaging of apoptosis

  • Imaging lymphomas

Other research tasks:

  • Co-chair research Medical Imaging Center

  • Responsible person for contract research Medical Imaging Center

  • Coordinator of the research line Oncology, Infection and Transplantation

  • Writing publications and grant applications

  • Writing Dutch (NFU, NVNG) and European (EANM) guidelines/recommendations

  • Reviewer of manuscripts

  • Collaboration with many external centers (Netherlands, Europe and worldwide) 

  1. The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

    Thorneloe, K. S., Sepp, A., Zhang, S., Galinanes-Garcia, L., Galette, P., Al-Azzam, W., Vugts, D. J., van Dongen, G., Elsinga, P., Wiegers, J., Glaudemans, A. W. J. M., Vincent, V., Renaux, J., Szapacs, M., Birchler, M., Cleveland, M., Bergstrom, M. & Davies, M., 21-May-2019, In : EJNMMI Research. 9, 12 p., 45.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Time for new imaging and therapeutic approaches in cardiac amyloidosis

    Slart, R. H. J. A., Glaudemans, A. W. J. M., Noordzij, W., Bijzet, J., Hazenberg, B. P. C. & Nienhuis, H. L. A., 23-Apr-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, 7, p. 1402-1406 5 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

View all (214) »

  1. Tekke Huizing price for best PhD thesis of 2014

    Andor Glaudemans (Recipient), 20-Nov-2014


View all (1) »

  1. Image-guided therapy

    Andor Glaudemans (Invited speaker)

    Activity: Participating in or organising an eventOrganising an eventAcademic

  2. 3rd advanced course Imaging infections and inflammation

    Andor Glaudemans (Invited speaker)

    Activity: Participating in or organising an eventOrganising an eventAcademic

  3. Inspiratiedag Coordineren en Sturen

    Andor Glaudemans (Invited speaker)

    Activity: Participating in or organising an eventOrganising an eventAcademic

View all (10) »

View graph of relations

ID: 496686